Amphastar pharmaceuticals, inc. (AMPH)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Sep'13Jun'13
Net revenues

327,255

322,357

328,664

324,070

316,063

294,666

265,378

247,751

241,898

240,175

243,316

249,623

252,469

255,165

268,534

268,179

253,999

251,519

230,484

226,327

221,477

210,461

213,902

216,715

0

0

0

Cost of revenues

189,412

190,434

195,433

196,831

195,147

187,681

172,701

163,781

157,245

149,666

153,220

152,468

150,347

150,969

151,135

160,814

165,030

174,172

174,347

175,977

169,449

159,205

154,327

141,442

0

0

0

Gross profit

137,843

131,923

133,231

127,239

120,916

106,985

92,677

83,970

84,653

90,509

90,096

97,155

102,122

104,196

117,399

107,365

88,969

77,347

56,137

50,350

52,028

51,256

59,575

75,273

0

0

0

Operating (income) expenses:
Selling, distribution, and marketing

12,983

12,830

11,950

10,692

9,576

8,156

7,189

6,982

6,702

6,460

6,322

5,857

5,593

5,466

5,282

5,162

5,300

5,470

5,662

5,945

5,827

5,564

5,527

5,276

0

0

0

General and administrative

44,698

50,279

53,588

55,974

55,217

49,888

45,295

43,553

44,118

44,458

45,940

45,076

42,300

41,832

39,840

38,073

39,923

41,504

42,563

43,085

40,415

34,809

34,584

31,541

0

0

0

Research and development

69,549

68,853

65,943

58,677

58,141

57,564

52,276

51,011

46,283

43,503

44,657

44,305

44,167

41,522

37,782

39,176

39,308

37,271

36,489

33,957

29,225

28,866

29,829

29,035

0

0

0

Gain on sale of intangible assets

-

-

-

-

-

-

-

-

-

2,643

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of long-lived assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

367

354

0

0

0

Total operating expenses

127,230

131,962

131,481

125,343

122,934

115,608

104,760

101,546

97,103

91,778

94,276

92,595

89,417

88,820

82,826

82,337

84,531

84,245

84,431

82,713

75,303

69,239

70,307

66,206

0

0

0

Income (loss) from operations

10,613

-39

1,750

1,896

-2,018

-8,623

-12,083

-17,576

-12,450

-1,269

-4,180

4,560

12,705

15,376

34,573

25,028

4,438

-6,898

-28,294

-32,363

-23,275

-17,983

-10,732

9,067

0

0

0

Non-operating (expenses) income:
Interest income

1,002

997

862

517

480

456

458

477

458

425

385

324

287

270

262

282

297

315

329

340

307

243

203

156

0

0

0

Interest expense

165

119

77

179

255

243

376

516

653

826

746

763

831

1,024

1,174

1,125

1,030

987

232

504

770

609

1,355

1,088

0

0

0

Other income (expenses), net

58,216

59,389

57,096

58,389

-2,877

-1,516

172

1,098

3,501

2,919

2,165

1,618

157

8

-3,754

-4,555

-4,056

-2,794

1,678

2,300

1,864

201

-112

-228

0

0

0

Total non-operating (expenses) income, net

59,053

60,267

57,881

58,727

-2,652

-1,303

254

1,059

3,306

2,518

1,804

1,179

-387

-746

-4,666

-5,398

-4,789

-3,466

1,775

2,136

1,401

-165

-1,264

-1,160

0

0

0

Income (loss) before income taxes

69,666

60,228

59,631

60,623

-4,670

-9,926

-11,829

-16,517

-9,144

1,249

-2,376

5,739

12,318

14,630

29,907

19,630

-351

-10,364

-26,519

-30,227

-21,874

-18,148

-11,996

7,907

0

0

0

Income tax provision (benefit)

17,482

13,723

12,163

12,523

-2,997

-3,266

-4,134

-7,305

-4,757

-2,398

-1,886

2,438

4,094

4,810

9,100

5,721

-718

-7,577

-13,678

-15,015

-12,129

-7,449

-3,659

3,055

0

0

0

Net income (loss)

52,184

46,505

47,468

48,100

-1,673

-6,660

-8,279

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to non-controlling interests

164

-2,434

-4,988

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) attributable to Amphastar Pharmaceuticals, Inc.

52,020

48,939

51,832

52,911

2,271

-5,738

-6,922

-9,212

-4,387

3,647

-490

3,301

8,224

9,820

20,807

13,909

367

-2,787

-12,841

-15,212

-9,745

-10,699

-8,337

4,852

0

0

0

Net income (loss) per share attributable to Amphastar Pharmaceuticals, Inc. shareholders:
Basic (in Dollars per share)

0.09

-0.02

0.03

1.01

0.02

0.04

0.05

-0.06

-0.15

0.02

0.00

0.04

0.02

-0.08

0.09

0.15

0.06

0.17

-0.07

-0.15

-0.01

-0.06

-0.12

-0.03

-0.04

0.00

0.20

Diluted (in Dollars per share)

0.08

-0.03

0.03

0.96

0.02

0.04

0.05

-0.06

-0.15

0.02

0.00

0.04

0.02

-0.07

0.08

0.15

0.05

0.17

-0.07

-0.15

-0.01

-0.06

-0.12

-0.03

-0.04

0.00

0.20

Weighted-average shares used to compute net income (loss) per share attributable to Amphastar Pharmaceuticals, Inc. shareholders:
Basic (in Shares)

46,408

46,838

47,239

47,107

46,744

46,268

46,241

46,557

46,514

46,233

46,101

46,025

46,069

46,104

45,398

44,957

45,041

45,084

45,310

44,849

44,601

44,648

44,644

39,767

38,769

38,709

38,708

Diluted (in Shares)

48,248

49,243

50,075

49,894

50,416

44,228

48,281

46,557

46,514

49,330

48,215

47,866

48,057

49,285

47,953

45,968

46,810

45,084

45,310

44,849

44,601

44,648

44,644

39,767

38,769

38,709

38,847